and in adults with type 2 diabetes mellitus. See Safety Info. which may affect their blood glucose. Click here for Full Prescribing Information for Lantus. starting dose for your patients with type 2 diabetes. See Safety Info. are rounded down to the nearest whole unit. (From LantusĀ® Prescribing Information.) . See Safety Info. or innovator, product; Currently, there are no FDA- approved AB/AP-rated follow-on biologic insulins1 More info on follow-on biologics +.

Author: Zologrel Dumi
Country: Sierra Leone
Language: English (Spanish)
Genre: Love
Published (Last): 22 September 2011
Pages: 186
PDF File Size: 9.51 Mb
ePub File Size: 17.11 Mb
ISBN: 636-9-31931-306-6
Downloads: 76112
Price: Free* [*Free Regsitration Required]
Uploader: Kajijar

Do not share your Prescribin SoloStar pen with infodmation people, even if lantus prescribing information needle has been changed. Lantus prescribing information these instructions completely each time you use SoloStar to ensure that you get an accurate dose. If the solution is cloudy, slightly colored, or has particles in it, do not use the Cartridge System. Individualize dosage based on metabolic lantus prescribing information, blood glucose monitoring, glycemic control, type of diabetes prior insulin use 2.

Vomiting or diarrhea that decreases the amount of sugar absorbed by your body. If you intend to travel abroad, make sure that you have sufficient needles and insulin with you. In clinical studies, the glucose-lowering effect on a molar basis i.

The following adverse reactions are discussed elsewhere: If you are using a new vial, remove the protective cap. Before each injection, carry out the Safety Test Step 3. Do not use the insulin after the expiration date stamped on the label, if it is colored or cloudy, or if you see particles lantus prescribing information the solution. Lantus prescribing information Check the label on your Cartridge System to make sure you have the correct insulin before injecting.

Patients were also treated with insulin lispro at mealtime.

Patients with pre-specified post-baseline eye procedures pan-retinal photocoagulation for proliferative informarion severe nonproliferative diabetic retinopathy, local photocoagulation for new vessels, and vitrectomy for diabetic retinopathy were lantus prescribing information considered as 3-step progressors regardless of actual change in ETDRS score from baseline. Instructions for Use How do I draw the insulin into the syringe?

Its onset may be rapid.

Mild episodes of hypoglycemia can usually be treated with oral carbohydrates. Patients lantus prescribing information renal or hepatic impairment may be at higher risk of hypoglycemia [See Use in Specific Populations 8.

Once-daily dose

If your injection is given by another person, special caution must be taken by this person to avoid accidental needle injury and transmission of infection. The Dosage Knob no longer turns after a new Cartridge System has been inserted: Unchanged drug and these degradation products are also present in the circulation.

Do not share disposable or reusable insulin devices or needles between patients, because doing so carries a risk for transmission of blood-borne pathogens. If your injection is given by informatio person, lanhus caution must be taken by this person when removing and disposing the needle. Patients should be advised lantus prescribing information to share disposable lantus prescribing information reusable insulin devices lantus prescribing information lantjs with other patients, because doing so carries a risk for transmission of blood-borne pathogens.

Good control of diabetes is especially important during pregnancy and nursing. If you are using a new vial, remove the protective cap.

Refer patients to the LANTUS “Patient Information” for additional information about the potential side effects of insulin therapy, including lipodystrophy and the need to rotate injection sites within the same body lantus prescribing informationweight gain, allergic reactions, and hypoglycemia.

In Study B, the average age was Slowly push in the plunger of the syringe all the way, making sure you have injected all lantus prescribing information insulin. Systemic Allergy Severe, life-threatening, generalized allergy, including anaphylaxis, generalized skin reactions, angioedema, bronchospasm, hypotension, and shock may occur with any insulin, including LANTUS and may be life threatening.

DailyMed – LANTUS – insulin glargin injection, solution

Intensification or rapid improvement in glucose control has been associated with a transitory, reversible ophthalmologic refraction disorder, worsening of diabetic retinopathy, and acute painful peripheral neuropathy. Lantus prescribing information Mitigation Strategies for Hypoglycemia.

This helps prevent contamination, and potential needle blocks. Medication errors have been reported in which other insulins, particularly rapid-acting insulins, have been lantus prescribing information administered instead of LANTUS [see Patient Counseling Information 17 ]. Regular human insulin was administered before each meal.

European Medicines Agency – System/website unavailable

Overall, the incidence lantus prescribing information major adverse cardiovascular outcomes was similar between groups see Table LLC Relabeling of “Additional” barcode label by: Enter section text here 5. Take extra insulin and supplies with you. Taking too much insulin. Lantus is a clear lantus prescribing information. Advise patients that changes in insulin regimen should be made under close medical supervision. Remove the protective seal from a new needle.

Do not use this SoloStar.